Clinical trials
Completed Alzheimer Disease trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
213 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 4 |
| 2006 | 7 |
| 2007 | 7 |
| 2008 | 13 |
| 2009 | 17 |
| 2010 | 12 |
| 2011 | 18 |
| 2012 | 18 |
| 2013 | 12 |
| 2014 | 16 |
| 2015 | 12 |
| 2016 | 9 |
| 2017 | 13 |
| 2018 | 9 |
| 2019 | 10 |
| 2020 | 4 |
| 2021 | 11 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 213 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 17 |
| University Hospital, Bordeaux | 13 |
| Centre Hospitalier Universitaire de Nice | 11 |
| University Hospital, Toulouse | 11 |
| Pfizer | 7 |
| University Hospital, Tours | 7 |
| University Hospital, Lille | 6 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 6 |
| CHU de Reims | 5 |
| Eli Lilly and Company | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 213 |
| Cognitive Dysfunction | 34 |
| Dementia | 34 |
| Neurodegenerative Diseases | 10 |
| Lewy Body Disease | 8 |
| Memory Disorders | 7 |
| Mental Disorders | 7 |
| Amyloidosis | 6 |
| Amyloid Neuropathies, Familial | 5 |
| Disease | 5 |
Trials
Showing 1 to 25 of 213. Each trial links to its page on Pharma Observatory.
113 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.